Ginsenoside Rc Ameliorates Endothelial Insulin Resistance via Upregulation of Angiotensin-Converting Enzyme 2.

MLA

Wang, Yaozhen, et al. “Ginsenoside Rc Ameliorates Endothelial Insulin Resistance via Upregulation of Angiotensin-Converting Enzyme 2.” Frontiers in Pharmacology, vol. 11, Feb. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.3389/fphar.2021.620524.

APA

Wang, Y., Fu, W., Xue, Y., Lu, Z., Li, Y., Yu, P., Yu, X., Xu, H., & Sui, D. (2021). Ginsenoside Rc Ameliorates Endothelial Insulin Resistance via Upregulation of Angiotensin-Converting Enzyme 2. Frontiers in Pharmacology, 11, N.PAG. https://doi.org/10.3389/fphar.2021.620524

Chicago

Wang, Yaozhen, Wenwen Fu, Yan Xue, Zeyuan Lu, Yuangeng Li, Ping Yu, Xiaofeng Yu, Huali Xu, and Dayun Sui. 2021. “Ginsenoside Rc Ameliorates Endothelial Insulin Resistance via Upregulation of Angiotensin-Converting Enzyme 2.” Frontiers in Pharmacology 11 (February): N.PAG. doi:10.3389/fphar.2021.620524.